Tuesday, June 5, 2018

Louisiana Board of Pharmacy Public Hearing Scheduled for June 25,2018

06-25-2018     Public Hearing

2018-1 ~ Pharmacy Benefit Managers [Source: Regulatory Proposal 2018-F]
               05-11-2018     1st Report submitted to Joint Legislative Oversight Committee on Health and Welfare.
               05-11-2018     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties, as well as all pharmacies, pharmacists, pharmacy interns, pharmacy technicians, and pharmacy technician candidates.
               05-20-2018     Notice of Intent scheduled for publication in Louisiana Register.
               06-25-2018     Public Hearing

Kansas Board of Pharmacy Meeting Scheduled for June 13-14, 2018

Board of Pharmacy Quarterly Meeting

Kansas City | Dates: 13 – 14 Jun, 2018

Indiana Board of Pharmacy Meeting Scheduled for June 11, 2018

  • June 11

Idaho Board of Pharmacy Agenda for Meeting Scheduled for June 7, 2018

Date: June 7, 2018
Location: Board of Pharmacy
Room: Public Conference Room
Map1199 Shoreline Ln 3rd Floor
Time (MDT): TBD
Agenda Deadline Request:4/12/2018

Idaho Board of Pharmacy Draft Minutes from Meeting on April 12, 2018

Hawaii Board of Pharmacy Minutes from Meeting on April 19, 2018

Hawaii Board of Pharmacy Meeting Scheduled for June 21, 2018

Thursday, June 21, 2018Queen Liliuokalani Conference Room

Georgia Board of Pharmacy Meeting Scheduled for June 6, 2018

Georgia Board of Pharmacy Meeting

Wednesday, June 6, 2018 - 9:00am
Athens

Georgia Board of Pharmacy Minutes from Meeting held on April 18, 2018

Florida Board of Pharmacy Minutes from meetings in April 2018

April 19, 2018 
Rules Subcommittee Meeting 
Best Western Gateway Grand Hotel and Conference Center
4200 NW 97th Blvd
Get Directions →Gainesville, FL 32606

1 (352) 331-3336 
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Minutes
 (PDF)
Meeting Audio
April 18, 2018 
Multidisciplinary Board Discussion on Implementing Rules Relating to Controlled Substances 
Telephone Conference Call @ 12pm EST
Meet Me #: 1 (888) 670-3525
Participation Code: 7342425515
Materials:
April 3 - April 4, 2018 
Board Meeting 
Residence Inn Tallahassee Universities at the Capitol
600 West Gaines Street
Get Directions →Tallahassee, Florida 32304

1(850) 329-9080 
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Minutes
 (PDF) 
Public Book
 (PDF)
Meeting Audio

Are you ready for the New Laws effective July 1, 2018 in Florida? Here is some of the new legislation

Effective Date: July 1, 2018
HB 675 (Full Text)
Summary:
Expands the eligibility for a membership seat on the Board of Pharmacy. Establishes and provides requirements for Class III institutional pharmacies and adds these pharmacies to those authorized to dispense prepackaged drug products.
If you’d like to view all 2018 bills impacting health care professions, please go to www.flhealthsource.gov/2018-bills

Effective Date: July 1, 2018
HB 513 (Full Text)
Summary:
Revises an exception to pharmacy regulations (Chapter 465, Florida Statutes) for certain manufacturers and distributers of dialysis drugs or supplies.

Effective Date: July 1, 2018
HB 351 (Full Text)
Summary:
Amends section 465.0244, Florida Statutes, providing requirements for pharmacists to inform customers of certain generically equivalent drug products and whether cost sharing obligations to such customers exceed the retail price of a prescription. Creates sections 624.490, 627.64741, 627.6572 and 641.314, Florida Statutes, establishing definitions, registration and duties involving prescription benefit managers and associated contracts. Repeals section 465.1862, Florida Statutes, regarding pharmacy benefits manager contracts.

HB 21 - Controlled Substances

Effective Date: July 1, 2018
HB 21 (Full Text)
Summary:
Creates section 456.0301, Florida Statutes, requiring practitioners to complete a specified board-approved continuing education course to prescribe controlled substances. The bill defines “acute pain” and establishes prescribing guidelines and grounds for disciplinary action if not followed. It limits opioid prescriptions for the treatment of acute pain to a specified period under certain circumstances and requires health care practitioners to check the prescription drug monitoring program (PDMP) database prior to prescribing or dispensing a controlled substance.
Additionally, the bill requires pain management clinics with an exemption from registration under section 458.3265 or 459.0137, Florida Statutes, to register their exemption with the Department of Health with no fee, and specifies a new certificate is required if a change of address occurs.
If you’d like to view all 2018 bills impacting health care professions, please go to www.flhealthsource.gov/2018-bills

find more here

Florida Board of Pharmacy Meetings Scheduled for June 2018

June 12, 2018 
Rules Committee 
Mission Inn Resort & Club
10400 County Road 48
Howey-in-the-Hills, Florida 34737

Get Directions →1 (800) 874-9053 
Materials:
FAR Notice (PDF)
June 12 - June 13, 2018 
Board Meeting 
Mission Inn Resort & Club
10400 County Road 48
Howey-in-the-Hills, Florida 34737

Get Directions →(800) 874-9053 
Materials:
FAR Notice (PDF)
June 21, 2018 
Joint Committee on Controlled Substances 
DoubleTree Hotel
5780 Major Boulevard
Orlando, Florida 32819

Get Directions →Online Reservation Information
(407) 351-1000 or 800-222-8733 
Materials:
FAR Notice (PDF)
Agenda (PDF) 
Public Book
 (PDF)

District of Columbia Board Meeting Scheduled for June 7, 2018

Delaware Board of Pharmacy New License Type

NEW LICENSE TYPE FOR WHOLESALE DISTRIBUTORS
Effective June 11, 2018, the new Third Party Logistics license goes in effect, see (Section 8.0 of the Board’s Rules and Regulations). For more information, click Distributor License.

Connecticut Board of Pharmacy Meeting Scheduled for June 20, 2018

 June 20, 2018

Monday, June 4, 2018

Colorado Board of Pharmacy Minutes from Meeting in April 2018

Colorado Board of Pharmacy Announces New Laws that Affect Colorado Prescribers, Limits Opioid Prescriptions

New Law Affects Colorado Prescribers, Limits Opioid Prescriptions

On Monday, May 21, 2018, Governor John Hickenlooper signed Senate Bill 18-22 Clinical Practice for Opioid Prescribing. The bill went into effect immediately upon the Governor’s signature. This new state law limits the number of opioid pills a healthcare provider can prescribe and affects physicians, physician assistants, advanced practice registered nurses with prescriptive authority, dentists, optometrists, podiatrists, and veterinarians.
Under the new law, a prescriber must limit a patient’s initial prescription of an opioid to a seven-day supply, if the prescriber has not written an opioid prescription for the patient in the last 12 months. The prescriber may exercise discretion in including a second fill for a seven-day supply. These limits do not apply, if, in the judgment of the prescriber, the patient:
  • Has chronic pain that typically lasts longer than 90 days or past the time of normal healing, as determined by the prescriber, or following transfer of care from another prescriber who prescribed an opioid to the patient;
  • Has been diagnosed with cancer and is experiencing cancer related pain; or
  • Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days.
After the first prescription, the prescriber is required to check the Prescription Drug Monitoring Program (PDMP) database before prescribing any additional opioids for the same patient. Failure to check the PDMP constitutes unprofessional conduct if the prescriber repeatedly fails to comply with this new requirement. The second fill requirement to check the PDMP does not apply when a patient:
  • Is receiving the opioid in a hospital, skilled nursing facility, residential facility, or correctional facility;
  • Has been diagnosed with cancer and is experiencing cancer related pain; or
  • Is undergoing palliative care or hospice care;
  • Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days;
  • Is receiving treatment during a natural disaster or during an incident where mass casualties have taken place; or has received only a single dose to relieve pain for a single test or procedure.
After the second opioid prescription, the law has no further restrictions on the healthcare provider’s prescribing practices. The new law does require a healthcare provider, or the provider’s designee, to specify the provider’s specialty upon the initial query of the PDMP.  It also states a violation of the new requirements does not constitute negligence or contributory negligence per se and does not create a private right of action or serve as the basis of a cause of action.

quoted from here

Colorado Board of Pharmacy Stakeholder Meeting Scheduled for June 11, 2018 Regarding possible amendments to board rules

Stakeholder Meeting - June 11

The Colorado State Board of Pharmacy is considering amending Board Rules 3.05.00, 6.00.00, 14.00.40, 14.00.80, 17.00.00 and 25.00.14 to improve the administration and enforcement of the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act.
Colorado law permits agencies to informally solicit views from interested stakeholders concerning proposed draft rules before commencing the formal rulemaking process. We invite you to share your thoughts and recommendations as we improve a preliminary draft of proposed rules to regulate the practice of pharmacy in Colorado. 
Draft Rules and Meeting Materials
  • Download the official stakeholder notice.
  • Download the draft rules for the meeting:
    • Rule 3.05.00 - The purpose of the proposed addition of Board Rule 3.05.00 is to specify the requirements for pharmacists when prescribing over-the-counter medications. 
    • Rule 6.00.00 - The purpose of any proposed amendments to Board Rule 6.00.00 is to address the requirements of drug therapy management. 
    • Rule 14.00.40 and 14.00.80 - The purpose of the proposed amendments to Board Rules 14.00.40 and 14.00.80 is to allow, and to address the corresponding consultant pharmacist expectations as to visitation frequency, a telepharmacy to dispense up to 50,000 dispensing units in a calendar year. 
    • Rule 17.00.00 - The purpose of the proposed amendments to Board Rule 17.00.00 is to address the education requirements to participate in statewide protocols as part of collaborative pharmacy. 
    • Rule 17.00.00 Appendix A
    • Rule 17.00.00 Appendix B
    • Rule 25.00.14 - The purpose of the proposed amendment to Board Rule 25.00.14 is to allow, and to address the corresponding expectations of involved pharmacists, the packaging and labeling of medication for a specific patient by an automated device at a specialized prescription drug outlet. 
Meeting Information
  • Monday, June 11, 2018 at 8:30 a.m. (MDT)
Three Ways to Participate
  1. In Person: Civic Center Plaza, 1560 Broadway, Conference Room 110D, Denver, CO 80202
  2. By Webinar: Register at https://attendee.gotowebinar.com/register/4125068951236793858.
  3. By Written Comment: Provide written comments in advance or after the meeting to dora_pharmacyboard@state.co.us no later than June 8, 2018, at 5 p.m. (MDT)
Meeting Format
Attendees may provide comments, concerns, and proposals to the program in writing or in person at the meeting. Participants will be able to discuss topics brought forward during the meeting. Program staff will moderate the discussion to ensure there is an equitable opportunity for all stakeholders to actively participate, and to ensure comments and suggested changes are collected for Board consideration and future rulemaking. This meeting is not a formal rulemaking hearing.
quoted from here

Arkansas Board of Pharmacy Proposed Regulation Changes: Public Hearing Scheduled for June 6, 2018

Proposed Regulation Changes

PUBLIC NOTICE
On Wednesday, June 6, 2018 at 9:00 AM, the Arkansas State Board of Pharmacy will hold a public hearing in the Arkansas State Board of Pharmacy Offices, 322 South Main, Suite 600, Little Rock, AR 72201.  The following regulation changes will be considered: 

REGULATION 5 - LONG-TERM-CARE FACILITIES 
Proposed changes will update language regarding destruction of unused drugs for long-term care facilities to remove outdated language, update emergency kit guidelines for use in long-term care and establish a list of emergency medications that can be used in Crisis Stabilization Units. 

REGULATION 7 – DRUG PRODUCTS/PRESCRIPTIONS 
Proposed changes will reduce regulatory burdens when transferring prescriptions between pharmacies and add language to specify that a pharmacist cannot dispense more of a schedule II narcotic medication than a prescriber can prescribe. 

REGULATION 8 – WHOLESALE DISTRIBUTION 
Proposed changes will clarify language in Regulation 8 to match statutory language in 17-92-108 and will also allow an outsourcing facility to operate under a single permit if they do not provide medications directly to patients.
Information about these proposed changes can be found in the PDF links below:  
(Deletions are in Red with Strikethrough and additions are Underlined in Blue
Public comments will be accepted until the conclusion of the public hearing. A copy of the proposed regulation changes can be obtained through our website at http://www.pharmacyboard.arkansas.gov/pharmacy-lawbookby calling (501) 682-0190, or writing:
Arkansas State Board of Pharmacy
322 South Main Street, Suite 600
Little Rock, AR 72201,
or by emailing the Board of Pharmacy at asbp@arkansas.gov

Arkansas Board of Pharmacy Agenda for Meeting Held June 5-6, 2018

Alabama Board of Pharmacy Meeting Scheduled for June 26-27, 2018

June 26 - 27, 2018 

Alabama Board of Pharmacy Proposing Adoption of New Rule and Amendment to an Existing Rule: Public Hearing Set for June 26, 2018

Proposed Adoption of New Rule 
Public Hearing Date 6/26/2018.
 
See proposed rule here


Proposed Amendment to an Existing Rule 
Public Hearing Date 6/26/2018.
 
See amendment here



The Medicine Shoppe, PHY 40626, Administrative Case AC 6013
Visalia, CA 
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the licensee is placed on probation for five years subject to the terms and conditions in the decision.
Decision effective 5/24/2018.
View the decision
Shiloh Family Pharmacy, PHY 51776, Administrative Case AC 5813
Los Angeles, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 5/24/2018.
View the decision
AmerisourceBergen Drug Corp., WLS 4383, Administrative Case AC 5078
Sacramento, CA
Through a disciplinary action of the Board, the license is subject to a public reproval.
Decision effective 5/24/2018.
View the decision
Cedar Pharmacy and Medical Supplies Inc., PHY 50262, Administrative Case AC 5488
Fresno, CA 
Through a disciplinary action of the Board, the license is revoked, the revocation is stayed, and the licensee is placed on probation for seven years subject to the terms and conditions in the decision.
Decision effective 6/1/2018.
View the decision

California Board of Pharmacy Agenda and Meeting Materials for Enforcement and Compounding Meeting Scheduled for June 7, 2018

June 7, 2018Department of Consumer Affairs
1625 N. Market Blvd.
1st Floor Hearing Room
Sacramento, CA 95834
AgendaMeeting Materials

California Board of Pharmacy Agenda and Meeting Material for Meeting Scheduled for June 6, 2018

June 6, 2018Department of Consumer Affairs
1625 N. Market Blvd.
1st Floor Hearing Room
Sacramento, CA 95834
AgendaMeeting Materials

Wyoming Board of Pharmacy June 2018 Newsletter (legislative update)

Virginia Board of Pharmacy June 2018 Newsletter (important information regarding new laws)

Tennessee Board of Pharmacy June 2018 Newsletter (a lot of important information regarding compounding, laws and DEA)

North Dakota Board of Pharmacy June 2018 Newsletter (USP 800 information)

New Mexico Board of Pharmacy June 2018 Newsletter (regulation changes)

Kentucky Board of :Pharmacy June 2018 Newsletter (important information regarding compounding pharmacy inspections)

Kansas Board of Pharmacy June 2018 Newsletter (important information regarding adoption of new laws)

Iowa Board of Pharmacy June 2018 Newsletter (see legislative update)

Idaho Board of Pharmacy June 2018 Newsletter (see legislative update)

District of Columbia June 2018 Newsletter

CVS also accused of forcing cancer patients to use their mail-order ...

Daily Mail-14 hours ago
Josh Cox, the pharmacy director for the Dayton Physicians Network, a large oncology practice in Ohio, says CVS has tried to bully their way into overtaking ...

State's Highest Court Rules Texas Must Reveal A Past Supplier Of ...

Texas Standard-2 hours ago
Texas has been fighting to keep a secret for years now – the name of the pharmacythat supplies its execution drugs. But late last week, after a lengthy court .

Big Pharma deserves more than wrist-slaps for opioid crisis | Editorial

Philly.com-10 hours ago
19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the maker of the prescription opioid painkille

How green is your pharmacy?

Australian Journal of Pharmacy (blog)-20 hours ago
A poster that looked into how pharmacies could be more environmentally friendly was recognised as the best poster by colleagues at the National Medicines ..

Texas Ordered to Reveal Its Execution Drug Supplier

Governing-6 hours ago
Rejecting an appeal from state officials, the Texas Supreme Court on Friday let stand a lower-court ruling requiring Texas to identify the pharmacy that supplied ...

Premixed Versus Compound IV Products for Patient Safety

Pharmacy Times-4 hours ago
At the ASHP 2018 Summer Meeting and Exhibition, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, talked about how ...

Pharmalittle: PBM mail order pharmacies hurting cancer patients ...

STAT-6 hours ago
Insurers and their pharmacy benefit managers tout mail-order pharmacies as convenient alternatives, but in the world of expensive cancer drugs, the companies .

There Might Be a Cheaper Drug, But Pharmacists Can't Tell You That

The Pew Charitable Trusts (blog)-8 hours ago
Kennedy had a friend behind the pharmacy counter where he went to fill the prescription. The pharmacist-friend said he would charge Kennedy the retail price 

Friday, June 1, 2018

Notice of Adopted Changes to the Regulations of the Board of Pharmacy - Alaska Online Public Notices

Notice of Adopted Changes to the Regulations of the Board of Pharmacy - Alaska Online Public Notices

Hot Topic: Texas must reveal compounding pharmacy it got execution drugs from, the Texas Supreme ...

Texas must reveal where it got execution drugs, the Texas Supreme ...

Texas Tribune-55 minutes ago
Since 2013, the department has used compounding pharmacies to obtain doses of pentobarbital, the drug it currently uses in executions. The state has not ..

Utah sues opioid maker Purdue Pharma after settlement talks stall

Reuters-22 hours ago
(Reuters) - Utah's attorney general on Thursday sued OxyContin maker Purdue Pharma LP to hold it responsible for its role in the opioid epidemic after he said ...

Whistleblower files lawsuit against CVS Caremark for falsifying drug ...

WKYC.com-13 hours ago
Ciaccia says, if you're a patient, this could impact the amount that you're paying at the pharmacy counter. It could over inflate your co-pay. But as a taxpayer this ...

Thursday, May 31, 2018

Disciplinary Action Against Mr Ethan Le

Lexology-9 hours ago
Background Facts. Mr Le was a registered pharmacist in Australia and worked as the PharmacyManager of the Abbotsford Point Pharmacy, New South Wales.

Philadelphia pharmacy owners pay $3.2M to settle fraud claims

Philadelphia Business Journal-8 hours ago
The owners of a Philadelphia pharmacy have agreed to pay $3.2 million to the federal government to resolve Medicare fraud allegations, according to the U.S. 

Pa. Pharmacy Owners Ink $3.2M False Billing Settlement

Law360-4 hours ago
Law360 (May 31, 2018, 5:40 PM EDT) -- A pair of Philadelphia pharmacy owners have agreed to a $3.2 million deal with the federal government over an ...